Literature DB >> 34348697

Breast conserving surgery using oxidized regenerated cellulose as filling biomaterial: recommendations to improve clinical outcomes.

Gianluca Franceschini1,2.   

Abstract

Oxidized regenerated cellulose is considered an optimal local hemostatic agent thanks to its favorable biocompatibility, absorption characteristics and ease-of-use. Recently, oxidized regenerated cellulose has also been used as a filler in breast conserving surgery with a reconstructive purpose in order to repair partial breast defects and improve aesthetic outcomes. However, some postoperative problems due to its use, such as allergic reactions, seroma, foreign-body reaction and misdiagnosis during the follow-up of breast cancer patients, have been shown. These possible surgical complications can undermine clinical outcomes and lead to delay the beginning of oncological treatments with a negative impact on patient quality of life and survival. An adequate surgical expertise and the compliance with some specific recommendations are crucial in order to minimize postoperative issues and optimise aesthetic outcomes.
© 2021. The Author(s).

Entities:  

Keywords:  Aesthetic results; Breast cancer; Breast conserving surgery; Hemostatic materials; Oxidized regenerated cellulose; Postoperative complications

Year:  2021        PMID: 34348697     DOI: 10.1186/s12905-021-01436-9

Source DB:  PubMed          Journal:  BMC Womens Health        ISSN: 1472-6874            Impact factor:   2.809


  9 in total

1.  Breast conserving surgery using volume replacement with oxidized regenerated cellulose: a cosmetic outcome analysis.

Authors:  Satoru Tanaka; Nayuko Sato; Hiroya Fujioka; Yuko Takahashi; Kosei Kimura; Mitsuhiko Iwamoto; Kazuhisa Uchiyama
Journal:  Breast J       Date:  2014 Mar-Apr       Impact factor: 2.431

2.  Oncoplastic breast surgery with oxidized regenerated cellulose: appraisals based on five-year experience.

Authors:  Gianluca Franceschini; Giuseppe Visconti; Riccardo Masetti
Journal:  Breast J       Date:  2014-05-26       Impact factor: 2.431

3.  Magnetic resonance imaging appearance of oxidized regenerated cellulose in breast cancer surgery.

Authors:  Michela Giuliani; Rossella Rella; Rita Fubelli; Federica Patrolecco; Silvia Eleonora Di Giovanni; Chiara Buccheri; Federico Padovano; Paolo Belli; Maurizio Romani; Pierluigi Rinaldi; Enida Bufi; Gianluca Franceschini; Lorenzo Bonomo
Journal:  Radiol Med       Date:  2016-06-04       Impact factor: 3.469

4.  Mammographic and Ultrasonographic Findings of Oxidized Regenerated Cellulose in Breast Cancer Surgery: A 5-Year Experience.

Authors:  Michela Giuliani; Rita Fubelli; Federica Patrolecco; Rossella Rella; Cristina Borelli; Chiara Buccheri; Silvia Eleonora Di Giovanni; Paolo Belli; Maurizio Romani; Pierluigi Rinaldi; Enida Bufi; Gianluca Franceschini; Lorenzo Bonomo
Journal:  Clin Breast Cancer       Date:  2015-03-24       Impact factor: 3.225

5.  Quadrantectomy with oxidized regenerated cellulose ("QUORC"): an innovative oncoplastic technique in breast conserving surgery.

Authors:  Gianluca Franceschini; Alejandro Martin Sanchez; Giuseppe Visconti; Alba Di Leone; Marzia Salgarello; Riccardo Masetti
Journal:  Ann Ital Chir       Date:  2015       Impact factor: 0.766

6.  Oxidized regenerated cellulose in breast surgery: experimental model.

Authors:  Gianluca Franceschini; Giuseppe Visconti; Alejandro Martin Sanchez; Alba Di Leone; Marzia Salgarello; Riccardo Masetti
Journal:  J Surg Res       Date:  2015-05-15       Impact factor: 2.192

7.  The role of oxidized regenerate cellulose to prevent cosmetic defects in oncoplastic breast surgery.

Authors:  G Franceschini; G Visconti; D Terribile; C Fabbri; S Magno; A Di Leone; M Salgarello; R Masetti
Journal:  Eur Rev Med Pharmacol Sci       Date:  2012-07       Impact factor: 3.507

8.  Clinical observation of the regeneration process of defects after breast cancer resection.

Authors:  Jun-Jie Li; Ye Yang; Qi Wan; Hui Li; Qi-Ming Long; Pu-Rong Zhang
Journal:  BMC Womens Health       Date:  2021-03-06       Impact factor: 2.809

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.